These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23017741)

  • 1. 2,4-D exposure and risk assessment: comparison of external dose and biomonitoring based approaches.
    Hays SM; Aylward LL; Driver J; Ross J; Kirman C
    Regul Toxicol Pharmacol; 2012 Dec; 64(3):481-9. PubMed ID: 23017741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomonitoring Equivalents (BE) dossier for 2,4-dichlorophenoxyacetic acid (2,4-D) (CAS No. 94-75-7).
    Aylward LL; Hays SM
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S37-48. PubMed ID: 18579270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new method for generating distributions of biomonitoring equivalents to support exposure assessment and prioritization.
    Phillips MB; Sobus JR; George BJ; Isaacs K; Conolly R; Tan YM
    Regul Toxicol Pharmacol; 2014 Aug; 69(3):434-42. PubMed ID: 24845241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective.
    Hays SM; Becker RA; Leung HW; Aylward LL; Pyatt DW
    Regul Toxicol Pharmacol; 2007 Feb; 47(1):96-109. PubMed ID: 17030369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomonitoring equivalents for DDT/DDE.
    Kirman CR; Aylward LL; Hays SM; Krishnan K; Nong A
    Regul Toxicol Pharmacol; 2011 Jul; 60(2):172-80. PubMed ID: 21466830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpreting biomonitoring data for 2,4-dichlorophenoxyacetic acid: Update to Biomonitoring Equivalents and population biomonitoring data.
    Aylward LL; Hays SM
    Regul Toxicol Pharmacol; 2015 Dec; 73(3):765-9. PubMed ID: 26577196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpreting human biomonitoring data in a public health risk context using Biomonitoring Equivalents.
    Hays SM; Aylward LL
    Int J Hyg Environ Health; 2012 Feb; 215(2):145-8. PubMed ID: 22192580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical-specific screening criteria for interpretation of biomonitoring data for volatile organic compounds (VOCs)--application of steady-state PBPK model solutions.
    Aylward LL; Kirman CR; Blount BC; Hays SM
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):33-44. PubMed ID: 20685286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human biomonitoring as a pragmatic tool to support health risk management of chemicals--examples under the EU REACH programme.
    Boogaard PJ; Hays SM; Aylward LL
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):125-32. PubMed ID: 20933039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomonitoring equivalents for deltamethrin.
    Aylward LL; Krishnan K; Kirman CR; Nong A; Hays SM
    Regul Toxicol Pharmacol; 2011 Jul; 60(2):189-99. PubMed ID: 21466827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ecological risk assessment of the exposure and effects of 2,4-D acid to rainbow trout (Onchorhyncus mykiss).
    Fairchild JF; Feltz KP; Allert AL; Sappington LC; Nelson KJ; Valle JA
    Arch Environ Contam Toxicol; 2009 May; 56(4):754-60. PubMed ID: 19165410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomonitoring Equivalents for benzene.
    Hays SM; Pyatt DW; Kirman CR; Aylward LL
    Regul Toxicol Pharmacol; 2012 Feb; 62(1):62-73. PubMed ID: 22178585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human biomonitoring assessment values: approaches and data requirements.
    Angerer J; Aylward LL; Hays SM; Heinzow B; Wilhelm M
    Int J Hyg Environ Health; 2011 Sep; 214(5):348-60. PubMed ID: 21764371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a screening approach to interpret human biomonitoring data on volatile organic compounds: reverse dosimetry on biomonitoring data for trichloroethylene.
    Liao KH; Tan YM; Clewell HJ
    Risk Anal; 2007 Oct; 27(5):1223-36. PubMed ID: 18076492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomonitoring Equivalents for bisphenol A (BPA).
    Krishnan K; Gagné M; Nong A; Aylward LL; Hays SM
    Regul Toxicol Pharmacol; 2010 Oct; 58(1):18-24. PubMed ID: 20541576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using Biomonitoring Equivalents to interpret human biomonitoring data in a public health risk context.
    Hays SM; Aylward LL
    J Appl Toxicol; 2009 May; 29(4):275-88. PubMed ID: 19115313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivation of Biomonitoring Equivalents for cyfluthrin.
    Hays SM; Aylward LL; Gagné M; Krishnan K
    Regul Toxicol Pharmacol; 2009 Dec; 55(3):268-75. PubMed ID: 19751788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomonitoring equivalents for di-isononyl phthalate (DINP).
    Hays SM; Aylward LL; Kirman CR; Krishnan K; Nong A
    Regul Toxicol Pharmacol; 2011 Jul; 60(2):181-8. PubMed ID: 21466828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.